October 2018 FDA Recall Drug by Akorn, Inc.
D-1208-2019 - Failed Impurities/Degradation Specifications; out of specification results observed for other individual impurities

This Class III drug recall was voluntarily initiated by Akorn, Inc. on October 29, 2018 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications; out of specification results observed for other individual impurities. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1208-2019

Reason for Recall
Failed Impurities/Degradation Specifications; out of specification results observed for other individual impurities
Initiated
10-29-2018
Reported
12-05-2018
Quantity
58,393 jars

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Nationwide USA and Puerto Rico
Clindamycin Phosphate Topical Solution USP, 1% (10 mg/mL clindamycin), 60 pledget applicators per jar, Rx only. Manufactured by Ei LLC 2865 N. Cannon Blvd. Kannapolis, NC 18083. NDC# 61748-0201-60

Batch or Lot Expiration Information

Lot# 2530200, Expiration date: 1/31/2019.
Lot# 2530300, Expiration date: 1/31/2019.
Lot# 2530400, Expiration date: 1/31/2019.
Lot# 2607300, Expiration date: 1/31/2019.
Lot# 2607400, Expiration date: 1/31/2019.
Lot# 2607500, Expiration date: 1/31/2019.
Lot# 2607600, Expiration date: 1/31/2019.
Lot# 2615800, Expiration date: 1/31/2019.
Lot# 2630200, Expiration date: 2/28/2019.
Lot# 2630300, Expiration date: 2/28/2019.